Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
Texto
Imagem
Documentos relacionados
Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women.. Delmas PD, Wahner HW, Mann KG,
Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY
The aim of this study was to determine the prevalence and factors associated with osteopenia and osteoporosis in women who have undergone bone mineral density test in a
bone mineral density, markers of bone turnover, age at first pregnancy, duration of lactation and other factors associated with osteoporosis in multiparous (five or more deliveries)
Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid- induced
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a
The aim of this study was to evaluate the sensitivity of the Osteorisk clinical tool for identifying Brazilian postmenopausal women with osteoporosis, compared with bone
Aim - To study a possible relationship between chronic gastritis, parietal cell density of the oxyntic mucosa and bone mineral density in postmenopausal women, as chronic